Long-term twice-daily oral acyclovir therapy suppresses frequently recurrent genital herpes

The efficacy of oral acyclovir in a twice-daily treatment regime was demonstrated in an open long-term study in 8 patients with frequently relapsing genital herpes type II infections. The treatment was well tolerated and no side effects were noted during the medication period of 6-21 months. No sign...

Full description

Saved in:
Bibliographic Details
Published inScandinavian journal of infectious diseases Vol. 19; no. 2; p. 273
Main Authors Molin, L, Bäck, O, Frödin, T, Svennerholm, B
Format Journal Article
LanguageEnglish
Published England 1987
Subjects
Online AccessGet more information

Cover

Loading…
More Information
Summary:The efficacy of oral acyclovir in a twice-daily treatment regime was demonstrated in an open long-term study in 8 patients with frequently relapsing genital herpes type II infections. The treatment was well tolerated and no side effects were noted during the medication period of 6-21 months. No signs of decreased sensitivity for acyclovir appeared.
ISSN:0036-5548
1651-1980
DOI:10.3109/00365548709032411